Baxion
Screening
Tags
Alerts
Theme
Quantum Biopharma Ltd.
QNTM
·
NASDAQ
·
$7.05
Share Price as of 11/2
·
$32M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
03/26/26
20-F/A
Annual report (foreign, amended)
03/31/25
20-F
Annual report (foreign)
03/28/25
20-F
Annual report (foreign)
04/02/24
20-F
Annual report (foreign)
03/31/23
Disclosures
Filter
6-K
Foreign issuer report
10/08/26
6-K
Foreign issuer report
10/06/26
6-K
Foreign issuer report
09/24/26
6-K
Foreign issuer report
09/17/26
6-K
Foreign issuer report
09/17/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
12/22/25
424B5
Prospectus supplement
10/31/25
424B5
Prospectus supplement
08/27/24
424B5
Prospectus supplement
02/20/24
F-3
Shelf registration (foreign)
12/26/23
Proxies
Filter
No matching filings.
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/05/26
SC 13G
Beneficial ownership
07/08/26
SC 13G/A
Beneficial ownership (amended)
02/03/26
SC 13G/A
Beneficial ownership (amended)
09/04/25
SC 13G/A
Beneficial ownership (amended)
07/18/25
Other
Filter
EFFECT
Request for effectiveness
01/04/24
CORRESP
Correspondence with the SEC
12/29/23
UPLOAD
Letter from the SEC
12/29/23
RW
Registration withdrawal
07/19/23
SUPPL
SUPPL
02/11/21
Latest Filings
Filter
6-K
Foreign issuer report
10/08/26
6-K
Foreign issuer report
10/06/26
6-K
Foreign issuer report
09/24/26
6-K
Foreign issuer report
09/17/26
6-K
Foreign issuer report
09/17/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/05/26
SC 13G
Beneficial ownership
07/08/26
SC 13G/A
Beneficial ownership (amended)
02/03/26
SC 13G/A
Beneficial ownership (amended)
09/04/25
SC 13G/A
Beneficial ownership (amended)
07/18/25